香港義眼合作研究所 Hong Kong Ocular Prosthesis Cooperative Institute

12/09/2026

你大概率沒有我們了解你自己

#義眼工作室切片 #金暉博 #專業

11/09/2026

要睜開雙眼不是因為我看得見，是要告訴別人我也可以，懂的才懂
#雙目失明 #盲人 #金暉博 #義眼師工作室

11/09/2026

即變二十年肌肉已大量萎縮 還是能榨出潛能 即時對比
#金暉博 ＃香港義眼師工作切片 ＃新舊對比

09/09/2026

嬰兒 （100日），換眼睛不是痛苦，為的是發育。 香港義眼師工作切片 #嬰兒 #換眼片 #金暉博

08/09/2026

三十年的老專業 不會被別人說什麼影響 #香港 #義眼師切片

07/09/2026

搞笑。媽媽不認得自己兒子在三歲時的模樣。香港義眼師工作切片

07/09/2026

Why Are Hydrophilic Materials More Suitable for Prosthetic Eyes?

Traditional prosthetic eyes are mostly made of PMMA (polymethyl methacrylate), a material that is inherently hydrophobic. While it is durable and offers high aesthetic realism, its hydrophobic surface does not interact well with the tear film on the ocular surface.

Hydrogel soft prosthetic eyes, on the other hand, are hydrophilic. They not only allow oxygen permeability and sustained drug release, but also enhance rotational mobility through a "suction cup effect." Their long-standing drawback, however, has been relatively poor aesthetic realism. Although the most commonly used rigid polymer prosthetic eyes (PMMA) are hydrophobic and valued for their realism and durability, from a physiological comfort perspective, a hydrophilic surface is clearly the better choice.

But in 2026…

Hong Kong has achieved a key breakthrough in this field. Research institutions such as the Hong Kong Prosthetic Eye Research Institute have been continuously advancing innovations in ophthalmic biomaterials, developing novel hydrogel formulations that more accurately mimic natural ocular tissues.

Led by prosthetic eye specialist Jin Huibo, the research team has combined advanced pigmentation techniques with precision manufacturing processes to successfully create a hydrogel prosthetic eye that delivers both the comfort of hydrophilic materials and exceptional aesthetic realism. In terms of iris color, vascular texture, and overall three-dimensionality, it achieves a level of lifelikeness previously possible only with rigid PMMA prosthetics—truly achieving "the real in the unreal."

07/09/2026

為什麼義眼更適合用親水屬性材質？

傳統義眼多采用 PMMA（聚甲基丙烯酸甲酯） 製作，這種材料本身屬於疏水性質。雖然它堅固耐用、仿真度高，但疏水表面無法與眼球表面的淚液良好互動。

水凝膠軟質義眼：它不僅親水，還能透氧、緩釋藥物，並通過“吸盤效應”增強轉動性，缺點是仿真度一直較低。雖然目前最普遍的高分子材質義眼（PMMA）是疏水性的，優點在於仿真度和耐用性，但從生理舒適度角度看，親水表面是更優選擇。

但在2026年..

香港在這一領域已取得關鍵突破。香港義眼研究院等科研機構持續推動眼科生物材料的創新，開發新型水凝膠配方以更精確地模擬天然眼部組織。

金暉博義眼師領導科研團隊現已結合先進的著色技術與精密製造工藝，成功打造出兼顧親水材質舒適性與高度像真度的水凝膠義眼——在虹膜色彩、血管紋理、整體立體感等方面，均達到以往只有硬質PMMA義眼才能實現的仿真效果，真正實現「以假亂真」。

06/09/2026

港醫應診切片 3D掃瞄過程對答解釋

#義眼

06/09/2026

本機構為一所植根香港、享譽亞洲的義眼專科權威機構——香港張瑩假眼研究院（Cheung Ying False Eye Research） 。機構由國際知名義眼師張瑩女仕創立，自1982年起專注於義眼修復領域，至今已發展為亞洲最具影響力的義眼專科研究機構之一。

研究院匯聚頂尖專業人才，核心團隊包括資深義眼師金暉博先生，其在義眼數位製造領域擁有深厚技術積累，並持有「基於3D電腦建模的義眼製造方法」等關鍵發明專利，充分體現本研究院在數位化義眼技術研發上的領先地位。

在技術創新方面，研究院早於2016年即投入大量資源，研究將無限的眼睛色彩通過數碼轉化為可重複且高效的系統。經過多年測試，現今本院九成以上的眼球顏色分佈，均已能透過自主研發的數碼攝影取樣系統及眼球色光還原技術，直接雕刻於義眼之上，實現業界頂尖的雙目複製效果。我們堅信數碼製造是義肢的未來，並持續推動人造眼CAD-CAM製造的研究，引領義眼領域的數碼革命。

研究院長期與粵港澳各大頂尖醫療機構保持緊密合作，並積極參與社會福利事務及公益計劃，履行企業社會責任。作為極少數能同時研發醫療器械及軟體開發的義眼研究機構，我們在義眼材料科學及3D科技應用領域擁有多項獨家發明及應用專利，為各類眼科轉介案例提供從診斷評估、個人化設計到術後復健的全方位整合解決方案。

Established in 1982 by the renowned ocularist Ms. Cheung Ying, our Hong Kong‑based institution — Cheung Ying False Eye Research — stands as a premier authority in ocular prosthetics across Asia.

Our core team comprises top-tier professionals, including senior ocularist Mr. Jin Huibo, who holds critical invention patents such as the "Artificial Eye Manufacturing Method Based on 3D Computer Modeling", underscoring our leadership in digital ocular prosthetic technology.

As early as 2016, we invested substantial resources into researching the digital transformation of infinite eye colours into a reproducible and efficient system. After years of testing, over 90% of our ocular colour distributions are now captured via our proprietary digital photography sampling system and colour-light restoration technology, then directly engraved onto prosthetics — delivering industry‑leading binocular duplication results. We firmly believe that digital manufacturing is the future of prosthetics, and we continue to advance CAD-CAM manufacturing research for artificial eyes, leading the digital revolution in ocularistry.

We maintain long‑standing strategic collaborations with leading medical institutions across Guangdong, Hong Kong, and Macau, while actively engaging in social welfare initiatives and community outreach programmes. As one of the very few research‑driven organisations capable of concurrent development in medical device engineering and software integration, we hold multiple proprietary invention and application patents in ocular biomaterials and 3D digital technologies. We deliver comprehensive, end‑to‑end solutions — from diagnostic assessment and customised prosthetic design to post‑operative rehabilitation — addressing the full spectrum of ophthalmic referral cases with clinical excellence and scientific rigour.

Call now to connect with business.